Pricing Log in Create free account

CDT Equity Inc. (CDT) vs Scinai Immunotherapeutics Ltd. Sponsored ADR (SCNI)

CDT Equity Inc. and Scinai Immunotherapeutics Ltd. Sponsored ADR are both Biotechnology companies. Scinai Immunotherapeutics Ltd. Sponsored ADR is the larger, with a market value of $640.0K against $240.0K — 2.7× the size. CDT Equity Inc. has negative trailing earnings, so its P/E is not meaningful; Scinai Immunotherapeutics Ltd. Sponsored ADR trades at 0.0×. Across the 9 metrics below, Scinai Immunotherapeutics Ltd. Sponsored ADR leads on 5 and CDT Equity Inc. on 4.

Valuation

Metric CDT SCNI Biotechnology median
P/E n/m 0.01 8.50
P/S n/m n/m 9.71
P/B n/m 0.05 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.28 0.64
EV/Sales n/m n/m 9.21
Earnings yield 372,911,481.96% 11,368.55% (33.15%)
Free cash flow yield (232,570.42%) (2,331.48%) (25.50%)

Profitability

Metric CDT SCNI Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (69.68%) 0.00% (56.36%)
Return on assets (55.16%) 0.00% (48.04%)
Return on invested capital (21.28%) 0.00% 0.00%

Growth

Metric CDT SCNI Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 52.16% (159.83%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CDT SCNI Biotechnology median
Debt to equity 0.00 0.02 0.00
Current ratio 0.13 1.56 4.72
Net debt to EBITDA 0.05 0.25 0.96

Dividend

Metric CDT SCNI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CDT SCNI Biotechnology median
Market cap 240.00k 640.00k 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack